7177 — GMO Financial Holdings Balance Sheet
0.000.00%
- ¥93bn
- ¥130bn
- ¥53bn
- 46
- 64
- 73
- 68
Annual balance sheet for GMO Financial Holdings, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 84,429 | 86,897 | 102,123 | 108,486 | 136,829 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 95,719 | 131,527 | 136,708 | 123,682 | 103,607 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 717,252 | 967,276 | 963,834 | 1,089,851 | 1,357,691 |
Net Property, Plant And Equipment | 1,136 | 1,830 | 1,867 | 1,483 | 1,291 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 725,367 | 996,049 | 991,482 | 1,125,498 | 1,394,818 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 676,377 | 929,835 | 912,796 | 1,023,139 | 1,273,382 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 689,392 | 955,345 | 951,884 | 1,079,067 | 1,346,701 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 35,975 | 40,704 | 39,598 | 46,431 | 48,117 |
Total Liabilities & Shareholders' Equity | 725,367 | 996,049 | 991,482 | 1,125,498 | 1,394,818 |
Total Common Shares Outstanding |